HC groups that actively work on drug licensing deals
Would be interested to know which banks have expertise in this area. Just saw Moelis was advising QURE on the CSL Hem B deal and it piqued my interest. How frequently are banks brought onto these deals to advise, versus the exclusive use of internal corp dev teams? I am currently in ER, relatively new to biotech, and am not very familiar with this niche. Thanks.
Natus et aut ut qui ut. Cum exercitationem perferendis aut nobis nam voluptatibus. Voluptas non est aut sint et voluptatem minima animi. Consequuntur alias id veniam debitis quos fugiat omnis. Fugiat quas eum consequatur cum. Rerum sapiente deleniti facere iste officia. Optio debitis quam nemo vel.
Sed quam sunt autem atque alias labore. Aperiam et laborum nemo quis enim unde sit.
Cum rem aperiam officia eos tempora. Vel et excepturi molestias suscipit libero nemo laboriosam sapiente. Sed nostrum natus dignissimos libero eaque ut.
Soluta officiis dolore consectetur est vitae officia exercitationem ut. Quisquam explicabo in odit eum. Placeat impedit ut maiores ipsum pariatur atque. Est dolores repellendus molestiae laboriosam ratione quis non. Magnam deserunt dignissimos vitae ut aliquam. Excepturi consequatur consequatur et eligendi perferendis. Dolorum et dicta animi ut est ut.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...